Bloomios, Inc. (BLMS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Dec 26, 2025
Bloomios Market Cap
Bloomios has a market cap or net worth of $6.79 thousand as of January 21, 2026. Its market cap has decreased by -99.95% in one year.
Market Cap
6.79K
Enterprise Value
n/a
Revenue
8.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 14, 2004, Bloomios's market cap has decreased from 4.27M to 6.79K, a decrease of -99.84%. That is a compound annual growth rate of -26.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 6.79K | -96.49% |
| Dec 29, 2023 | 193.42K | -98.57% |
| Dec 30, 2022 | 13.54M | -43.90% |
| Dec 31, 2021 | 24.13M | 95.29% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |